ATE401351T1 - Lignankomplexe - Google Patents

Lignankomplexe

Info

Publication number
ATE401351T1
ATE401351T1 AT03735732T AT03735732T ATE401351T1 AT E401351 T1 ATE401351 T1 AT E401351T1 AT 03735732 T AT03735732 T AT 03735732T AT 03735732 T AT03735732 T AT 03735732T AT E401351 T1 ATE401351 T1 AT E401351T1
Authority
AT
Austria
Prior art keywords
lignan
complexes
complex
cyclodextrin
disclosed
Prior art date
Application number
AT03735732T
Other languages
English (en)
Inventor
Tomi Jaervinen
Pekka Jarho
Mikko Unkila
Mervi Hiilovaara-Teijo
Original Assignee
Hormos Medical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hormos Medical Ltd filed Critical Hormos Medical Ltd
Application granted granted Critical
Publication of ATE401351T1 publication Critical patent/ATE401351T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
    • A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
    • A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/0006—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid
    • C08B37/0009—Homoglycans, i.e. polysaccharides having a main chain consisting of one single sugar, e.g. colominic acid alpha-D-Glucans, e.g. polydextrose, alternan, glycogen; (alpha-1,4)(alpha-1,6)-D-Glucans; (alpha-1,3)(alpha-1,4)-D-Glucans, e.g. isolichenan or nigeran; (alpha-1,4)-D-Glucans; (alpha-1,3)-D-Glucans, e.g. pseudonigeran; Derivatives thereof
    • C08B37/0012—Cyclodextrin [CD], e.g. cycle with 6 units (alpha), with 7 units (beta) and with 8 units (gamma), large-ring cyclodextrin or cycloamylose with 9 units or more; Derivatives thereof
    • C08B37/0015—Inclusion compounds, i.e. host-guest compounds, e.g. polyrotaxanes
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Polymers & Plastics (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Food Science & Technology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medical Informatics (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nutrition Science (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
AT03735732T 2002-08-29 2003-06-24 Lignankomplexe ATE401351T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20021545A FI114917B (fi) 2002-08-29 2002-08-29 Lignaanikomplekseja

Publications (1)

Publication Number Publication Date
ATE401351T1 true ATE401351T1 (de) 2008-08-15

Family

ID=8564494

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03735732T ATE401351T1 (de) 2002-08-29 2003-06-24 Lignankomplexe

Country Status (9)

Country Link
US (1) US20050249857A1 (de)
EP (1) EP1554316B1 (de)
AT (1) ATE401351T1 (de)
AU (1) AU2003238106A1 (de)
DE (1) DE60322244D1 (de)
DK (1) DK1554316T3 (de)
ES (1) ES2310663T3 (de)
FI (1) FI114917B (de)
WO (1) WO2004020474A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100396783C (zh) * 2006-03-07 2008-06-25 谭兴起 络石藤的木脂素苷元总提取物的提取工艺方法及其产品
EP2517574B1 (de) * 2011-04-29 2015-11-11 Symrise AG Bestimmte Vanillyllignane und deren Verwendung als Geschmacksverbesserer
JP7079931B2 (ja) * 2018-05-10 2022-06-03 淳三 亀井 セサミノールとシクロデキストリンとの包接複合体及びその製造方法
KR102143405B1 (ko) 2018-11-16 2020-08-11 한국화학연구원 리그난 포접물 및 이의 제조 방법

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3070611B2 (ja) * 1989-03-07 2000-07-31 サントリー株式会社 △▲上５▼―不飽和化酵素阻害剤
EP0818196B1 (de) * 1989-07-21 2004-12-29 Suntory Limited Kapsel, enthaltend ein Dioxabicyclo(3.3.0)oktan
US6261565B1 (en) * 1996-03-13 2001-07-17 Archer Daniels Midland Company Method of preparing and using isoflavones
US6413533B1 (en) * 1998-05-07 2002-07-02 The University Of Tennessee Research Corporation Method for chemoprevention of prostate cancer
US6689809B2 (en) * 1999-03-30 2004-02-10 Hormos Nutraceutical Oy Ltd. Food additive or product or a pharmaceutical preparation, comprising hydroxymatairesinol
US6451849B1 (en) * 1999-03-30 2002-09-17 Hormos Nutraceutical Oy Ltd. Use of hydroxymatairesinol for prevention of cancers, non-cancer, hormone dependent diseases and cardiovascular diseases by hydroxymatairesinol, and a pharmaceutical preparation, food additive and food product comprising hydroxymatairesinol
OA12542A (en) * 2001-01-31 2006-06-05 Pfizer Prod Inc Thiazolyl-, oxazolyl-, pyrrolyl-, and imidazolyl-acid amide derivatives useful as inhibitors of PDE4isozymes.
FI20021184L (fi) * 2002-06-19 2003-12-20 Hormos Nutraceutical Oy Ltd Lignaanivalmisteita

Also Published As

Publication number Publication date
EP1554316A1 (de) 2005-07-20
EP1554316B1 (de) 2008-07-16
AU2003238106A1 (en) 2004-03-19
FI20021545L (fi) 2004-03-01
DE60322244D1 (de) 2008-08-28
US20050249857A1 (en) 2005-11-10
FI20021545A0 (fi) 2002-08-29
FI114917B (fi) 2005-01-31
WO2004020474A1 (en) 2004-03-11
ES2310663T3 (es) 2009-01-16
DK1554316T3 (da) 2008-11-17

Similar Documents

Publication Publication Date Title
BRPI0412254A (pt) produtos aril-heteroaromáticos, composições que os contêm e utilização
NO20084337L (no) Cartenoid-inneholdende kost supplement
LUC00065I2 (de)
BRPI0510364A (pt) detecção e tipagem de cepas bacterianas
CA2233108A1 (en) Complex of y-cyclodextrin and retinol or retinol derivatives, processes for their preparation and their use
AU2003303458A1 (en) Ampholytic copolymer and use thereof
MY142017A (en) Composition comprising all essential nutrients of a fruit or a plant material with increased stability and bioavailability and process of forming the same
CY1109996T1 (el) Ανοσογονικη συνθεση
NO20075540L (no) Lignian-inneholdende sammensetninger
SE0202529D0 (sv) Food composition product
DE60108325D1 (de) Pharmazeutische oder diätetische zusammensetzungen aus pilzen und deren verwendung
ITRM990376A0 (it) Composizione comprendente sfingomielinasi alcalina, utilizzabile quale prodotto dietetico, integratore alimentare o medicamento.
WO2007109071A3 (en) Hydroxylated polymethoxyflavone compositions
IL165389A0 (en) Piperidine derivatives and pharmaceutical compositions containing the same
AU2003205710A1 (en) Use of anti-adhesive packaging materials for packaging chemicals and food
DE60322244D1 (de) Lignankomplexe
PT1292570E (pt) Sal de creatina que possui uma eficacia nutricional e terapeutica melhorada e composicoes que o contem
DE50000168D1 (de) Orale darreichungsform
FI20021822A0 (fi) Elintarvike
WO2006109194A3 (en) Chromium-fatty acid compounds and methods of making and using thereof
PL1615656T3 (pl) Produkt immunomodulatorowy otrzymany z hodowli bifidobacterium i zawierające go kompozycje
DE602007007784D1 (de) Präbiotikumhaltiges flüssiges nahrungsmittelprodukt
UA46474S (uk) 1. розгортка опаковання для дієтичної добавки
UA45832S (uk) 1. розгортка опаковання для дієтичної добавки
WO2004002953A3 (fr) Composes lactones, utilisables en tant qu'agents antioxydants dans des compositions pharmaceutiques, cosmetiques ou alimentaires

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties